Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of investors, who currently hold shares of Aratana Therapeutics, Inc. (NASDAQ: PETX), was announced concerning whether the takeover of Aratana Therapeutics, Inc.. is unfair to NASDAQ: PETX stockholders. The investigation by a law firm concerns whether certain officers and directors of Aratana Therapeutics, Inc. breached their fiduciary duties owed to NASDAQ:...
You must register (for free) or login to view the entire investigation.